Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 34910155.
- Also identified by DOI 10.1001/jamanetworkopen.2021.38975 and PMC identifier 8674742.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This case-control study examines estimated COVID-19 messenger RNA vaccination effectiveness against SARS-CoV-2 infection from January to September 2021 among fully vaccinated male veterans aged 65 years or older.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- RNA, Messenger
- Vaccination
- Veterans
- Veterans Health